SEC Form 4 · accession 0001209191-18-058010
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernst Heinen
Officer — Chief Development Officer
Period of report
Nov 7, 2018
Accepted (ET)
Nov 9, 2018 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2018 | S | 19,308 | $6.95 | D | 135,694 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This sale constitutes the final sale under such trading plan.